Vericel Corp (VCEL)

• Market cap: $1.8B
• 1 day: -5.31%
• 5 days: -6.18%
• 1 month: -2.46%
• 3 months: -11.35%
• 6 months: -0.59%
• Year to date: 0.2%
• 1 year: -28.09%
• 5 years: -25.93%
• 10 years: 1,666.34%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 357